PBT2 potentiates carbapenem antibiotics against diverse <i>Klebsiella pneumoniae</i> strains. [PDF]
Tan A +9 more
europepmc +1 more source
Antimicrobial activity of aztreonam/avibactam and molecular characterization of Enterobacterales not susceptible to ceftazidime/avibactam and/or meropenem/vaborbactam from US medical centres (2016-2024). [PDF]
Sader HS +5 more
europepmc +1 more source
Global epidemiology of carbapenem-resistant <i>Pseudomonas aeruginosa</i>. [PDF]
Gottesdiener LS, Satlin MJ.
europepmc +1 more source
Secondary hemophagocytic lymphohistiocytosis complicating culture-confirmed ceftriaxone-resistant <i>Salmonella typhi</i> infection: A rare case report. [PDF]
Akter H +5 more
europepmc +1 more source
Prediction of Meropenem Target Attainment in Critically Ill Patients Using Routine Clinical Data from a Single Center: A Machine Learning Approach. [PDF]
Lu Q +5 more
europepmc +1 more source
JDB-1-200, an Atypically Modified Carbapenem with Standalone In Vitro Activity against KPC-Producing Enterobacterales. [PDF]
Hassan T +9 more
europepmc +1 more source
A Review on the Structural Evolution and Clinical Evidence of Boronic Acid β-Lactamase Inhibitors. [PDF]
Zou W, Zhu L.
europepmc +1 more source
Recent Advances and Future Perspectives in the Detection of Carbapenem-Resistant <i>Acinetobacter Baumannii</i>. [PDF]
Ye Q +6 more
europepmc +1 more source
Pyridoxic Acid as a Novel Endogenous Biomarker for OAT-Mediated Clearance of Meropenem: A Population Pharmacokinetic Modeling and PK/PD-Response Analysis in Patients with Sepsis. [PDF]
Lei Z +12 more
europepmc +1 more source

